Form 8-K - Current report:
SEC Accession No. 0001641172-25-000917
Filing Date
2025-03-27
Accepted
2025-03-27 16:03:28
Documents
33
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38747
2 ex99-1.htm EX-99.1 63950
3 ex99-2.htm EX-99.2 13773
4 ex99-2_001.jpg GRAPHIC 439130
5 ex99-2_002.jpg GRAPHIC 1503088
6 ex99-2_003.jpg GRAPHIC 482441
7 ex99-2_004.jpg GRAPHIC 704100
8 ex99-2_005.jpg GRAPHIC 668337
9 ex99-2_006.jpg GRAPHIC 719486
10 ex99-2_007.jpg GRAPHIC 759138
11 ex99-2_008.jpg GRAPHIC 902264
12 ex99-2_009.jpg GRAPHIC 635496
13 ex99-2_010.jpg GRAPHIC 458400
14 ex99-2_011.jpg GRAPHIC 432086
15 ex99-2_012.jpg GRAPHIC 761580
16 ex99-2_013.jpg GRAPHIC 634992
17 ex99-2_014.jpg GRAPHIC 751398
18 ex99-2_015.jpg GRAPHIC 1086229
19 ex99-2_016.jpg GRAPHIC 745389
20 ex99-2_017.jpg GRAPHIC 567586
21 ex99-1_001.jpg GRAPHIC 3392
  Complete submission text file 0001641172-25-000917.txt   17152148

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE ltrn-20250327.xsd EX-101.SCH 3030
23 XBRL LABEL FILE ltrn-20250327_lab.xml EX-101.LAB 34240
24 XBRL PRESENTATION FILE ltrn-20250327_pre.xml EX-101.PRE 24175
35 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3783
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 25779224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)